chr13-20143113-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_021954.4(GJA3):c.176C>T(p.Pro59Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Consequence
GJA3
NM_021954.4 missense
NM_021954.4 missense
Scores
16
2
1
Clinical Significance
Conservation
PhyloP100: 9.87
Genes affected
GJA3 (HGNC:4277): (gap junction protein alpha 3) The protein encoded by this gene is a connexin and is a component of lens fiber gap junctions. Defects in this gene are a cause of zonular pulverulent cataract type 3 (CZP3). [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a topological_domain Extracellular (size 30) in uniprot entity CXA3_HUMAN there are 9 pathogenic changes around while only 0 benign (100%) in NM_021954.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.984
PP5
Variant 13-20143113-G-A is Pathogenic according to our data. Variant chr13-20143113-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 217339.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-20143113-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJA3 | NM_021954.4 | c.176C>T | p.Pro59Leu | missense_variant | 2/2 | ENST00000241125.4 | NP_068773.2 | |
GJA3 | XM_011535048.3 | c.176C>T | p.Pro59Leu | missense_variant | 2/2 | XP_011533350.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJA3 | ENST00000241125.4 | c.176C>T | p.Pro59Leu | missense_variant | 2/2 | 3 | NM_021954.4 | ENSP00000241125 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 34
GnomAD4 exome
Cov.:
34
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cataract 14 multiple types Pathogenic:4
Pathogenic, criteria provided, single submitter | curation | Dept. Genetics and Cancer, Menzies Institute for Medical Research, University of Tasmania | Jan 21, 2023 | Variant identified and curated during a GJA3 specific review of the literature in relation to pediatric or congenital cataract. ACMG-AMP criteria applied: PP1(Strong), PS4(Moderate), PM1, PM2(Supporting) PP3. The cataract phenotype/s reported for this variant are: Punctate nuclear, Pulverulent, Lamellar, and Central (Nuclear). Original variant report: PMID:15208569;19182255;21866213;25148791;27609163;26694549;34169787;36161833. Gene review and curation guidelines are outlined in: https://doi.org/10.1080/17469899.2023.2160320 - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 09, 2019 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. This variant has been reported in individuals and families with congenital cataracts segregating with disease (PMID: 15208569, 26694549, 19182255, 27609163). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with leucine at codon 59 of the GJA3 protein (p.Pro59Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. - |
Pathogenic, criteria provided, single submitter | research | Miami Human Genetics, University Of Miami Miller School Of Medicine | May 09, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
Developmental cataract Pathogenic:2
Likely pathogenic, criteria provided, single submitter | research | Dept. Genetics and Cancer, Menzies Institute for Medical Research, University of Tasmania | May 01, 2021 | - - |
Pathogenic, no assertion criteria provided | research | Eye Genetics Research Group, Children's Medical Research Institute | Jan 09, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Gain of catalytic residue at E62 (P = 0.0062);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at